Omeros Corp. buy tamam
Start price
21.12.17
/
50%
€17.58
Target price
01.01.19
€29.77
Performance (%)
-42.84%
End price
01.01.19
€10.05
Summary
This prediction ended on 01.01.19 with a price of €10.05. The BUY prediction by tamam for Omeros Corp. performed very badly with a performance of -42.84%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | -2.614% | -2.614% | 22.203% | 297.333% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
Comments by tamam for this prediction
In the thread Omeros Corp. diskutieren
tamam stimmt der Buy-Einschätzung von marge zu
tamam stimmt am 21.12.2017 der Buy-Einschätzung von marge, aber mit dem Kursziel 33$ zu.
Überschrift: Orphan drug market support blockbuster potential for OMS721
(Laufzeit überschritten)